TWAICE
31.3.2021 12:14:12 CEST | Business Wire | Press release
TWAICE provides predictive analytics software that optimizes the development and operation of batteries. For the energy sector this means enhanced transparency and predictability of stationary battery storages. The results are optimized storage operations and reduced technology risks. The battery experts are now expanding their portfolio with an Operating Strategy Planner, a surefire method to extract maximum profit from stationary energy storages.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210331005480/en/
Major utility companies are among the first customers to connect to the Operating Strategy Planner. According to Stephan Rohr, Co-CEO at TWAICE, others will soon follow suit: “There has been huge interest in the Operating Strategy Planner, which empowers owner and operator decision-making to deliver significant increases in return on investment for energy storage portfolios. We are delighted to have major utilities as first customers of this cutting-edge new product”.
Batteries are pivotal to the success of renewable energy. Their capacity to store and generate energy on demand is unique. It makes them a vital element of the storage solutions required to stabilize grids in the face of fluctuating and decentralized energy generation. As highly complex systems, batteries must be expertly managed if optimum performances are to be consistently delivered. The key: transparency into battery aging behavior.
Stationary energy storage use cases and operational constraints have differing effects on battery degradation. This has a large impact on the individual business case and risk profile. The TWAICE Operating Strategy Planner enables users to create scenarios and conduct sensitivity analyses for different use cases and boundary conditions. They can compare the scenarios and find the optimum and learn how long the storage will last with the selected strategy.
The software empowers storage operators and owners to achieve optimal returns under consideration of battery health. This means deploying sophisticated multi-use strategies and identifying the right mix, for example of intraday trading and frequency response. The algorithms that market the capacity of battery storages are provided with the most profitable boundary conditions for operation. The opportunity costs of each trade can be assessed, and the profits are maximized. All of this, while reducing the overall risk of unexpected battery aging over the lifetime.
TWAICE provides analytics software that optimizes the development and operation of lithium-ion batteries. TWAICE’s core technology is a software that combines deep battery knowledge and artificial intelligence to determine the condition and predict the aging and performance of batteries. As the leading battery analytics software for players in the mobility and energy sectors, TWAICE is committed to increasing the lifetime, efficiency, reliability, and sustainability of the products that power the economy of tomorrow.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210331005480/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom